Quetiapine Fumarate 150 mg/1 (Quetiapine Fumarate TABLET, EXTENDED RELEASE) 150 mg/1

Quetiapine Fumarate 150 mg extended-release tablets are used to manage certain mental health conditions. This medication is designed for oral use and is manufactured by Novast Laboratories, Ltd.

Strength

150 mg/1

Pack Size

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-636-30)

Manufacturer / TM Owner

Novast Laboratories, Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Quetiapine Fumarate 150 mg extended-release tablets are commonly used to help manage symptoms of mental health conditions. This medication is often prescribed to help with conditions that may involve mood stabilization or sleep regulation. People often ask, 'What is Quetiapine Fumarate used for?' and it is typically used as part of a treatment plan for conditions that may require extended-release medication.

Side Effects

Quetiapine Fumarate 150 mg extended-release tablets may cause drowsiness, dizziness, or dry mouth. Some users may experience weight changes or fatigue. It is important to note that individual responses to medication can vary, and not everyone will experience the same effects.

Precautions & Warnings

Quetiapine Fumarate 150 mg extended-release tablets should be stored at room temperature and kept out of reach of children. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Quetiapine Fumarate 150 mg extended-release tablets may interact with alcohol, other sedatives, or medications that affect the central nervous system. It is also important to be cautious when taking this medication with other drugs that may cause drowsiness. Always consult a healthcare professional before starting any new medication.

Frequently Asked Questions

Quetiapine Fumarate is commonly used to manage symptoms of certain mental health conditions, often involving mood stabilization or sleep regulation.

Quetiapine Fumarate 150 mg extended-release tablets are designed for oral use. Follow the administration instructions provided by your healthcare professional.

Common side effects may include drowsiness, dizziness, dry mouth, weight changes, or fatigue. Individual responses can vary.

It is generally advised to avoid alcohol while taking Quetiapine Fumarate, as it may increase the risk of side effects.

Store Quetiapine Fumarate tablets at room temperature and keep them out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.